15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Alvotech, 2 rate it Buy or better, 1 sit at Hold, and 1 rate it Sell or worse, a hold consensus. The target range is very wide, $4.00 to $14.00 (about 3.5x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $8.00 sits 156% above the current $3.12. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 12% this year and 19% next, consensus EPS building from about $0.02 next quarter toward $0.23 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Hold
Strong Buy00%
Buy250%
Hold125%
Sell125%
Strong Sell00%
Based on 4 analysts giving stock ratings to Alvotech.
As of Jul, 2 of 4 firms rate ALVO a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
ALVO EPS & revenue forecast
EPS · NEXT QUARTER
$0.02
Range $0.02 – $0.02 · 1 analysts · -116% YoY
Next period, 1 analysts expect Alvotech to earn $0.02 a share (range $0.02 – $0.02), versus $-0.11 a year earlier. Full-year consensus is $0.03, growing to $0.23 the year after.
REVENUE · NEXT QUARTER
$181.1M
Range $161.0M – $201.1M · 1 analysts · +52% YoY
Revenue is expected to reach $181.1M (range $161.0M – $201.1M), +52.0% year-over-year. Full-year consensus is $660.8M, rising to $799.8M next year.
Top analysts covering Alvotech
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ALVO.
#1
Ashwani Verma
UBS
Buy
$6.00+92.3% to target
Coverage
—
+ Follow
#2
GS
Glen Santangelo
Barclays
Sell
$4.00+28.2% to target
Coverage
—
+ Follow
#3
Carl Byrnes
Northland Capital Markets
Buy
$10.00+220.5% to target
Coverage
—
+ Follow
#4
NA
Niall Alexander
Deutsche Bank
Hold
$8.00+156.4% to target
Coverage
—
+ Follow
#5
TB
Thibault Boutherin
Morgan Stanley
Buy
$14.00+348.7% to target
Coverage
—
+ Follow
ALVO stock forecast FAQ
What is ALVO's average 12-month price target?+
The 4 analysts with a live target average $8.00 for Alvotech over the next 12 months, ranging from a $14.00 high to a $4.00 low.
Is ALVO stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 4 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for ALVO?+
The Street-high target is $14.00 (Morgan Stanley), and the Street-low is $4.00 (Barclays). The average of all 4 active targets is $8.00.
How many Wall Street analysts cover ALVO?+
4 analysts have an active rating on Alvotech, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering ALVO?+
Among analysts who currently cover ALVO, Ashwani Verma of UBS has the strongest overall Quantellect track record. Their current call is Buy with a $6.00 target.
What is Alvotech's projected EPS for next quarter?+
The consensus estimate is $0.02 per share (range $0.02 – $0.02) across 1 analysts. Full-year EPS is projected at $0.03, rising to $0.23 the following year.
How much revenue is Alvotech expected to report next quarter?+
Consensus revenue is $181.1M (range $161.0M – $201.1M). Full-year revenue is projected at $660.8M, growing to $799.8M next year.
Have analysts been upgrading or downgrading ALVO lately?+
As of Jul, 2 of 4 firms rate ALVO a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ALVO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
